⚡ Asset Showdown Engine

UNH vs CVS

Head-to-head financial comparison for UnitedHealth Group Inc (UNH) and CVS Health Corp (CVS).

🏆 Showdown Verdict

UNH leads CVS in 10 of 17 key financial metrics.

UNH: 10 wins · CVS: 7 wins
NEW YORK STOCK EXCHANGE, INC. · Health Care

UNH

UnitedHealth Group Inc
$416.86
-0.62%
After hours
52-Week Range 78.2% of High
Low: $255.97 High: $461.62
💼
Profitability Winner Higher Operating & Net Margins
🚀
Performance Winner Higher Historical Returns
🏛️
Scale Leader Larger Market Cap
NEW YORK STOCK EXCHANGE, INC. · Health Care

CVS

CVS Health Corp
$416.86
-0.62%
🌆 After hours
🌆 After-Hours: $416.59 (-0.10%)
52-Week Range 78.2% of High
Low: $255.97 High: $461.62
💼
Profitability Winner Higher Operating & Net Margins
🚀
Performance Winner Higher Historical Returns
🏛️
Scale Leader Larger Market Cap
NEW YORK STOCK EXCHANGE, INC. · Health Care

CVS

CVS Health Corp
$93.45
-1.34%
🌆 After hours
🌆 After-Hours: $93.85 (+0.43%)
52-Week Range 58.1% of High
Low: $69.51 High: $110.68
🏷️
Valuation Winner Lower P/E & Multiples
💰
Income Winner Higher Dividend Yield

Normalized % Return Comparison

Both assets indexed to 0.0% at the period start: ((Price_t - Price_0) / Price_0 * 100)

Benchmark:
UNH (UnitedHealth Group Inc) +20.02%
CVS (CVS Health Corp) +18.41%
UNH leads by +1.61%
-36.1%-14.8%+6.5%+27.8%+49.1% Oct '25Jan '26Apr '26Jul '26Oct '26

Metric-by-Metric Breakdown

Direct quantitative comparison across valuation, margins, growth, and returns.

Financial Metric UNH CVS Showdown Advantage
Valuation & Multiples
Price Current market price per share / unit $416.86 $93.45 —
Market Capitalization Total aggregate market value of equity $375.88B $121.44B 👑 UNH Larger
P/E Ratio (Trailing TTM) Price-to-earnings multiple (lower positive is cheaper) 23.76x 24.83x 👑 UNH Cheaper
Forward P/E Price-to-projected next year earnings multiple 17.09x 10.37x 👑 CVS Lower
PEG Ratio P/E divided by earnings growth rate (<1.0 considered undervalued) 1.48 1.96 👑 UNH Lower
Price to Sales (P/S) Price relative to trailing revenue 0.84x 0.29x 👑 CVS Lower
Price to Book (P/B) Stock price relative to book equity per share 3.16x 1.66x 👑 CVS Lower
Profitability & Margins
Gross Profit Margin Gross revenue retained after cost of goods sold — 14.15% 👑 CVS Higher
Operating Margin Operating income generated per dollar of revenue 5.25% 2.11% 👑 UNH Higher
Net Profit Margin Net bottom-line profit generated per dollar of revenue 3.53% 1.18% 👑 UNH Higher
Return on Equity (ROE) Net income earned per dollar of shareholders' equity 16.10% 6.41% 👑 UNH Higher
Historical Performance & Growth
Revenue Growth (YoY) Year-over-year top-line revenue expansion rate -0.41% +7.26% 👑 CVS Higher
1-Month % Return Historical total price return over the past 30 days +11.06% +1.93% 👑 UNH Higher
6-Month % Return Historical total price return over the past 180 days +37.39% +20.35% 👑 UNH Higher
1-Year % Return Historical total price return over the past 52 weeks +20.02% +18.41% 👑 UNH Higher
5-Year % Return Historical total price return over 5 years +1.58% +25.30% 👑 CVS Higher
Dividends & Risk
Dividend Yield Annual dividend distributions relative to current price 1.37% 3.49% 👑 CVS Higher
Beta (Volatility vs S&P 500) Market sensitivity (1.0 = equal to market, <1.0 = lower volatility) 0.54 0.58 —
52-Week High & Low Extreme trading boundaries over trailing year $255.97 – $461.62 $69.51 – $110.68 —